FDA warning letter
Closeout letter
Issue date
28 Oct 2019
Issuing office
Division of Pharmaceutical Quality Operations I
Posted date
19 Nov 2019
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Issue date
18 Mar 2022
FDA warning letter
Issue date
8 Oct 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
15 Oct 2019
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs